Budesonide vs Risankizumab
National NHS prescribing compared (Prescription Cost Analysis)
Budesonide was dispensed 8,602.0× as often as Risankizumab in April 2026 — 8,602 items versus 1 in England.
8,602items
Budesonide · April 2026
NHSBSA Prescription Cost Analysis
1items
Risankizumab · April 2026
NHSBSA Prescription Cost Analysis
Figure 1. Budesonide versus Risankizumab: national items dispensed by month
▬ Budesonide · ╌ Risankizumab
Source: NHSBSA Prescription Cost Analysis, to April 2026
| Measure | Budesonide | Risankizumab |
|---|---|---|
| Items, April 2026 | 8,602 | 1 |
| Items, last 12 months | 102,078 | 1 |
| Net ingredient cost, April 2026 | £827,971 | £3,326 |
See the full profile for Budesonide or Risankizumab.